Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metabolic Signatures Predictive of Response to Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer

NCT07084610 is registered in ClinicalTrials.gov with Hospital das Clínicas de Ribeirão Preto as lead sponsor.

NCT NCT07084610
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07084610 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metabolic Signatures Predictive of Response to Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer
Lead sponsor
Hospital das Clínicas de Ribeirão Preto
Phase
Phase 2
Overall status
Recruiting
Start date
February 25, 2025
Completion date
January 31, 2029
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer